CDKN2A and esophageal squamous cell carcinoma: The mechanism of CDKN2A loss in this case—oncogenic mutation accompanied by heterozygous deletion—is consistent with the EAC diagnosis, as the mechanism of CDKN2A loss in ESCC is homozygous deletion (Figure 7D).